83.86
price up icon0.71%   0.5757
 
loading
前日終値:
$83.28
開ける:
$83.45
24時間の取引高:
83,595
Relative Volume:
0.02
時価総額:
$48.66B
収益:
$5.88B
当期純損益:
$1.34B
株価収益率:
35.70
EPS:
2.3489
ネットキャッシュフロー:
$799.60M
1週間 パフォーマンス:
-0.13%
1か月 パフォーマンス:
-0.25%
6か月 パフォーマンス:
+10.65%
1年 パフォーマンス:
+14.28%
1日の値動き範囲:
Value
$83.44
$84.00
1週間の範囲:
Value
$83.08
$87.89
52週間の値動き範囲:
Value
$65.94
$87.89

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
名前
Edwards Lifesciences Corp
Name
セクター
Healthcare (1133)
Name
電話
(949) 250-2500
Name
住所
ONE EDWARDS WAY, IRVINE, CA
Name
職員
15,800
Name
Twitter
@edwardslifesci
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
EW's Discussions on Twitter

EW を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
EW
Edwards Lifesciences Corp
83.84 48.33B 5.88B 1.34B 799.60M 2.3489
Medical Devices icon
ABT
Abbott Laboratories
120.89 210.84B 43.84B 13.90B 6.92B 7.9725
Medical Devices icon
BSX
Boston Scientific Corp
91.92 137.17B 19.35B 2.78B 3.82B 1.8696
Medical Devices icon
SYK
Stryker Corp
349.61 133.55B 24.38B 2.94B 4.07B 7.6159
Medical Devices icon
MDT
Medtronic Plc
100.18 127.71B 34.76B 4.79B 5.21B 3.7017

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-03 アップグレード Raymond James Mkt Perform → Outperform
2025-10-29 アップグレード Jefferies Hold → Buy
2025-10-29 アップグレード Wolfe Research Underperform → Peer Perform
2025-10-08 ダウングレード Oppenheimer Outperform → Perform
2025-10-07 アップグレード Evercore ISI In-line → Outperform
2025-07-29 アップグレード BTIG Research Neutral → Buy
2025-04-24 アップグレード Piper Sandler Neutral → Overweight
2025-01-30 アップグレード Stifel Hold → Buy
2025-01-16 ダウングレード Wolfe Research Peer Perform → Underperform
2024-12-16 アップグレード BofA Securities Neutral → Buy
2024-10-11 再開されました Morgan Stanley Equal-Weight
2024-09-18 ダウングレード Jefferies Buy → Hold
2024-07-31 アップグレード Daiwa Securities Neutral → Outperform
2024-07-29 アップグレード Wolfe Research Underperform → Peer Perform
2024-07-25 ダウングレード BofA Securities Buy → Neutral
2024-07-25 ダウングレード JP Morgan Overweight → Neutral
2024-07-25 ダウングレード Robert W. Baird Outperform → Neutral
2024-07-25 ダウングレード TD Cowen Buy → Hold
2024-07-25 ダウングレード Truist Buy → Hold
2024-05-30 開始されました Goldman Buy
2024-05-22 アップグレード Citigroup Neutral → Buy
2024-05-14 アップグレード Deutsche Bank Hold → Buy
2024-03-07 アップグレード BofA Securities Neutral → Buy
2024-02-02 アップグレード Wells Fargo Equal Weight → Overweight
2024-01-04 ダウングレード Evercore ISI Outperform → In-line
2023-12-11 ダウングレード Citigroup Buy → Neutral
2023-11-28 ダウングレード Wolfe Research Peer Perform → Underperform
2023-09-26 アップグレード Oppenheimer Perform → Outperform
2023-07-19 開始されました Robert W. Baird Outperform
2023-05-30 再開されました Morgan Stanley Overweight
2023-03-29 開始されました UBS Neutral
2023-03-08 ダウングレード Wells Fargo Overweight → Equal Weight
2023-02-06 ダウングレード Raymond James Outperform → Mkt Perform
2023-01-31 ダウングレード Bernstein Outperform → Underperform
2023-01-30 ダウングレード Piper Sandler Overweight → Neutral
2022-12-06 ダウングレード Stifel Buy → Hold
2022-10-28 ダウングレード Oppenheimer Outperform → Perform
2022-10-26 開始されました Mizuho Buy
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Buy
2022-07-29 ダウングレード Canaccord Genuity Buy → Hold
2022-04-13 開始されました Truist Buy
2022-04-06 開始されました Wolfe Research Outperform
2022-03-16 アップグレード Bernstein Mkt Perform → Outperform
2022-03-02 再開されました BofA Securities Neutral
2022-02-02 アップグレード UBS Neutral → Buy
2022-01-27 繰り返されました Citigroup Buy
2022-01-27 繰り返されました Evercore ISI Outperform
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました Stifel Buy
2022-01-27 繰り返されました UBS Neutral
2021-12-17 アップグレード JP Morgan Neutral → Overweight
2021-12-15 アップグレード Citigroup Neutral → Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-12-06 アップグレード Wells Fargo Equal Weight → Overweight
2021-07-30 繰り返されました Canaccord Genuity Buy
2021-07-30 繰り返されました Deutsche Bank Hold
2021-07-30 繰り返されました Jefferies Buy
2021-07-30 繰り返されました Morgan Stanley Overweight
2021-07-30 繰り返されました Oppenheimer Outperform
2021-07-30 繰り返されました Stifel Buy
2021-07-30 繰り返されました UBS Neutral
2021-07-30 繰り返されました Wells Fargo Equal Weight
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-04-05 アップグレード Evercore ISI In-line → Outperform
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-12-11 繰り返されました Canaccord Genuity Buy
2020-09-11 開始されました Wolfe Research Underperform
2020-04-28 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 アップグレード SVB Leerink Mkt Perform → Outperform
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-10 開始されました Oppenheimer Outperform
2020-01-02 ダウングレード Evercore ISI Outperform → In-line
2019-10-24 繰り返されました Canaccord Genuity Buy
2019-09-23 開始されました Piper Jaffray Overweight
2019-07-24 繰り返されました BofA/Merrill Buy
2019-03-18 繰り返されました Canaccord Genuity Buy
2019-01-18 アップグレード BofA/Merrill Neutral → Buy
2019-01-03 開始されました Deutsche Bank Hold
2018-11-28 開始されました UBS Neutral
2018-10-16 開始されました Barclays Underweight
2018-10-02 ダウングレード BofA/Merrill Buy → Neutral
2018-10-02 ダウングレード Guggenheim Buy → Neutral
すべてを表示

Edwards Lifesciences Corp (EW) 最新ニュース

pulisher
Dec 09, 2025

Scott Ullem Sells 7,700 Shares of Edwards Lifesciences (NYSE:EW) Stock - MarketBeat

Dec 09, 2025
pulisher
Dec 09, 2025

Vega Investment Solutions Has $28,000 Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat

Dec 09, 2025
pulisher
Dec 09, 2025

Edwards Lifesciences Corporation $EW Shares Purchased by Natixis - MarketBeat

Dec 09, 2025
pulisher
Dec 09, 2025

Edwards Lifesciences Corporation $EW Shares Acquired by Ossiam - MarketBeat

Dec 09, 2025
pulisher
Dec 09, 2025

Edwards Lifesciences’ Markowitz sells $50k in stock By Investing.com - Investing.com Canada

Dec 09, 2025
pulisher
Dec 09, 2025

Edwards Lifesciences Corporation $EW Stock Position Increased by 2Xideas AG - MarketBeat

Dec 09, 2025
pulisher
Dec 08, 2025

Edwards Lifesciences’ Markowitz sells $50k in stock - Investing.com

Dec 08, 2025
pulisher
Dec 08, 2025

Barclays Raises Edwards Lifesciences (EW) Price Target to $103.0 - GuruFocus

Dec 08, 2025
pulisher
Dec 08, 2025

Leerink Partners Adjusts Edwards Lifesciences PT to $87 From $88, Maintains Market Perform Rating - marketscreener.com

Dec 08, 2025
pulisher
Dec 08, 2025

WINTON GROUP Ltd Acquires 43,197 Shares of Edwards Lifesciences Corporation $EW - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

Edwards Lifesciences stock price target raised to $95 from $90 at Bernstein - Investing.com

Dec 08, 2025
pulisher
Dec 07, 2025

Invesco Ltd. Decreases Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat

Dec 07, 2025
pulisher
Dec 06, 2025

Edwards Lifesciences (NYSE:EW) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

Edwards Lifesciences (NYSE:EW) Price Target Raised to $100.00 at Royal Bank Of Canada - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

Epoch Investment Partners Inc. Has $20.45 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

Edwards Lifesciences (EW): Stifel Raises Price Target to $100 | - GuruFocus

Dec 06, 2025
pulisher
Dec 06, 2025

Edwards Lifesciences (EW) Sees Analyst Target Price Increase Tod - GuruFocus

Dec 06, 2025
pulisher
Dec 06, 2025

Amundi Raises Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat

Dec 06, 2025
pulisher
Dec 06, 2025

UBS Maintains Neutral Rating on Edwards Lifesciences (EW) and Ra - GuruFocus

Dec 06, 2025
pulisher
Dec 05, 2025

Will Edwards Lifesciences’ (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative? - Yahoo Finance

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences (EW) Analyst Rating Update for December 5, 2025 | EW Stock News - GuruFocus

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences (EW): Reassessing Valuation After Upbeat 2025–2026 Outlook and TAVR Growth Signals - Yahoo Finance

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences Sets Cautious Targets Yet Keeps Investors Interested - Finimize

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences : EW 2025 IC FINAL - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Bernstein Adjusts Edwards Lifesciences Price Target to $95 From $90, Maintains Market Perform Rating - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Wells Fargo Adjusts Price Target for Edwards Lifesciences (EW) | - GuruFocus

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences Bags Prosthetic Valve Patent In EU - Law360

Dec 05, 2025
pulisher
Dec 05, 2025

Truist Securities Raises Price Target for Edwards Lifesciences (EW) | EW Stock News - GuruFocus

Dec 05, 2025
pulisher
Dec 05, 2025

How Do Investors Really Feel About Edwards Lifesciences Corp? - Benzinga

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences stock hits 52-week high at 87.42 USD By Investing.com - Investing.com Nigeria

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences stock hits 52-week high at 87.42 USD - Investing.com

Dec 05, 2025
pulisher
Dec 05, 2025

Raymond James Adjusts PT on Edwards Lifesciences to $100 From $96, Maintains Outperform Rating - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

UBS Adjusts Price Target on Edwards Lifesciences to $92 From $90, Maintains Neutral Rating - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences price target raised to $92 from $90 at UBS - Investing.com

Dec 05, 2025
pulisher
Dec 05, 2025

RBC Capital raises Edwards Lifesciences stock price target to $100 on 2026 outlook - Investing.com

Dec 05, 2025
pulisher
Dec 05, 2025

Truist Securities Adjusts PT on Edwards Lifesciences to $92 From $90, Maintains Hold Rating - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences price target raised to $100 from $95 at Stifel - TipRanks

Dec 05, 2025
pulisher
Dec 05, 2025

RBC Raises Price Target on Edwards Lifesciences to $100 From $95, Keeps Outperform Rating - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Stifel Adjusts Price Target on Edwards Lifesciences to $100 From $95, Maintains Buy Rating - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Wells Fargo Adjusts Price Target on Edwards Lifesciences to $96 From $95, Maintains Overweight Rating - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Barclays Adjusts Price Target on Edwards Lifesciences to $103 From $99, Maintains Overweight Rating - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Canaccord Genuity Adjusts Price Target on Edwards Lifesciences to $89 From $84, Maintains Hold Rating - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences price target raised to $89 from $84 at Canaccord - TipRanks

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences stock price target raised to $92 from $90 at Truist - Investing.com Nigeria

Dec 05, 2025
pulisher
Dec 05, 2025

Analyst BTIG Raises Price Target for Edwards Lifesciences (EW) t - GuruFocus

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences stock price target raised to $100 by Stifel - Investing.com South Africa

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences price target raised to $96 from $95 at Wells Fargo - TipRanks

Dec 05, 2025
pulisher
Dec 05, 2025

Does Edwards Lifesciences’ Analyst Day Transcatheter Pipeline Update Reframe the Bull Case for EW? - simplywall.st

Dec 05, 2025
pulisher
Dec 05, 2025

Edwards Lifesciences stock price target raised to $89 from $84 at Canaccord - Investing.com

Dec 05, 2025

Edwards Lifesciences Corp (EW) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$82.70
price down icon 0.57%
$66.08
price down icon 0.23%
medical_devices PHG
$26.73
price down icon 0.28%
medical_devices STE
$256.96
price up icon 0.59%
$294.52
price down icon 0.27%
大文字化:     |  ボリューム (24 時間):